Effects of Th1 and Th2 cells balance in pulmonary injury induced by nano titanium dioxide

Environmental Toxicology and Pharmacology

Volumn 37, Issue 1, 2014, Pages 275-283

  Chang, Xuhong ^a   Fu, Yanyun ^a   Zhang, Yingjian ^a   Tang, Meng ^a,b   Wang, Bei ^a  

^a SOUTHEAST UNIVERSITY   (China)

^b Southeast University   (China)

Author keywords

Immune response; Nano TiO2; Pulmonary injury; Th1; Th2

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 4; MESSENGER RNA; NANOTITANIUM DIOXIDE; TITANIUM DIOXIDE; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR T BET; UNCLASSIFIED DRUG;

ALVEOLAR THICKNESS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; CELL EXPANSION; CELL METABOLISM; CELL ORGANELLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ACTIVITY; DISEASE ASSOCIATION; DOWN REGULATION; ENDOPLASMIC RETICULUM; GENE EXPRESSION; HISTOPATHOLOGY; HYPEREMIA; IMMUNE RESPONSE; LUNG ALVEOLUS WALL; LUNG INJURY; MACROPHAGE; MALE; MITOCHONDRION; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RESPIRATORY TRACT PARAMETERS; TH1 TH2 BALANCE; TRANSMISSION ELECTRON MICROSCOPY; UPREGULATION;

IMMUNE RESPONSE; NANO TIO(2); PULMONARY INJURY; TH1; TH2;

ANIMALS; CYTOKINES; LUNG; LUNG INJURY; MALE; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; T-BOX DOMAIN PROTEINS; TH1 CELLS; TH2 CELLS; TITANIUM;

EID: 84891479718     PISSN: 13826689     EISSN: 18727077     Source Type: Journal    
DOI: 10.1016/j.etap.2013.12.001     Document Type: Article

References (40)

1. IARC Carbon black, titanium dioxide, and talc. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans 2010, vol. 93:1-413. World Health Organization, International Agency for Research on Cancer.
2. Bermudez E., Mangum J.B., Wong B.A., Asgharian B., Hext P.M., Warheit D.B., Everitt J.I. Pulmonary responses of mice, rats, and hamsters to subchronic inhalation of ultrafine titanium dioxide particles. Toxicological Sciences 2004, 77:347-357.
3. Borm P.J.A., Robbins D., Haubold S., Kuhlbusch T., Fissan H., Donaldson K., Schins R., Stone V., Kreyling W., Lademann J., Krutmann J., Warheit D., Oberdorster E. The potential risks of nanomaterials: a review carried out for ECETOC. Particle and Fibre Toxicology 2006, 3:11.
4. Chang C. The immune effects of naturally occurring and synthetic nanoparticles. Journal of Autoimmunity 2010, 34:J234-J246.
5. Chua T.C., Yao P., Akther J., Morris D.L. Impact of tumor angiogenesis in peritoneal mesothelioma after radical cytoreduction and hyperthermic intraperitoneal chemotherapy. Pathology & Oncology Research 2010, 16:217-222.
6. Chua T.C., Yao P., Akther J., Young L., Bao S.S., Samaraweera U., Yan T.D., Morris D.L. Differential expression of Ki-67 and sex steroid hormone receptors between genders in peritoneal mesothelioma. Pathology & Oncology Research 2009, 15:671-678.
7. Dwivedi P.D., Tripathi A., Ansari K.M., Shanker R., Das M. Impact of nanoparticles on the immune system. Journal of Biomedical Nanotechnology 2011, 7:193-194.
8. Finotto S. T-cell regulation in asthmatic diseases. Chemical Immunology Allergy 2008, 83-92. Karger, Basel.
9. Finotto S., De Sanctis G.T., Lehr H.A., Herz U., Buerke M., Schipp M., Bartsch B., Atreya R., Schmitt E., Galle P.R., Renz H., Neurath M.F. Treatment of allergic airway inflammation and hyperresponsiveness by antisense-induced local blockade of GATA-3 expression. Journal of Experimental Medicine 2001, 193:1247-1260.
10. Gioacchino M., Petrarca C., Lazzarin F., Di Giampaolo L., Sabbioni E., Boscolo P., Mariani-Costantini R., Bernardini G. Immunotoxicity of nanoparticles. International Journal of Immunopathology and Pharmacology 2011, 24:65S-71S.
11. Gustafsson A., Lindstedt E., Elfsmark L.S., Bucht A. Lung exposure of titanium dioxide nanoparticles induces innate immune activation and long-lasting lymphocyte response in the dark Agouti rat. Journal of Immunotoxicology 2011, 8:111-121.
12. Hext P.M., Tomenson J.A., Thompson P. Titanium dioxide: inhalation toxicology and epidemiology. Annals of Occupational Hygiene 2005, 49:461-472.
13. Hussain S., Vanoirbeek J.A.J., Hoet P.H.M. Interactions of nanomaterials with the immune system. Wiley Interdisciplinary Reviews - Nanomedicine and Nanobiotechnology 2012, 4:169-183.
14. Iavicoli I., Leso V., Bergamaschi A. Toxicological effects of titanium dioxide nanoparticles: a review of in vivo studies. Journal of Nanomaterials 2012, 15:481-508.
15. Jovanovic B., Anastasova L., Rowe E.W., Zhang Y., Clapp A.R., Palic D. Effects of nanosized titanium dioxide on innate immune system of fathead minnow (Pimephales promelas Rafinesque, 1820). Ecotoxicology and Environmental Safety 2011, 74:675-683.
16. Kim C.H. Chemokine-chemokine receptor network in immune cell trafficking. Current Drug Targets - Immune Endocrine and Metabolic Disorders 2004, 4:343-361.
17. Lantelme E., Mantovani S., Palermo B., Campanelli R., Sallusto F., Giachino C. Kinetics of GATA-3 gene expression in early polarizing and committed human T cells. Immunology 2001, 102:123-130.
18. Lee H.J., Takemoto N., Kurata H., Kamogawa Y., Miyatake S., O'Garra A., Arai N. GATA-3 induces T helper cell type 2 (Th2) cytokine expression and chromatin remodeling in committed Th1 cells. Journal of Experimental Medicine 2000, 192:105-115.
19. Liang G.Y., Pu Y.P., Yin L.H., Liu R., Ye B., Su Y.Y., Li Y.F. Influence of different sizes of titanium dioxide nanoparticles on hepatic and renal functions in rats with correlation to oxidative stress. Journal of Toxicology and Environmental Health. Part A. Current Issues 2009, 72:740-745.
20. Lighvani A.A., Frucht D.M., Jankovic D., Yamane H., Aliberti J., Hissong B.D., Nguyen B.V., Gadina M., Sher A., Paul W.E., O'Shea J.J. T-bet is rapidly induced by interferon-gamma in lymphoid and myeloid cells. Proceedings of the National Academy of Sciences of the United States of America 2001, 98:15137-15142.
21. Liu R., Yin L., Pu Y., Liang G., Zhang J., Su Y., Xiao Z., Ye B. Pulmonary toxicity induced by three forms of titanium dioxide nanoparticles via intra-tracheal instillation in rats. Progress in Natural Science 2009, 19:573-579.
22. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25:402-408.
23. Matthews I.P., Gregory C.J., Aljayyoussi G., Morris C.J., McDonald L., Hoogendoorn B., Gumbleton M. Maximal extent of translocation of single-walled carbon nanotubes from lung airways of the rat. Environmental Toxicology and Pharmacology 2013, 35:461-464.
24. 2. Review of in vivo data. Environmental Pollution 2011, 159:677-684.
25. Moon E.-Y., Yi G.-H., Kang J.-S., Lim J.-S., Kim H.-M., Pyo S. An increase in mouse tumor growth by an in vivo immunomodulating effect of titanium dioxide nanoparticles. Journal of Immunotoxicology 2011, 8:56-67.
26. Pietroiusti A. Health implication of engineered nanomaterials. Nanoscale 2012, 4:1231-1247.
27. 2 particles inhibits features of allergic asthma in a murine model. Particle and Fibre Toxicology 2010, 7:1-17.
28. Sager T.M., Kommineni C., Castranova V. Pulmonary response to intratracheal instillation of ultrafine versus fine titanium dioxide: role of particle surface area. Particle and Fibre Toxicology 2008, 5.
29. 2 nanoparticles. Inhalation Toxicology 2012, 24:528-538.
30. Szabo S.J., Kim S.T., Costa G.L., Zhang X.K., Fathman C.G., Glimcher L.H. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 2000, 100:655-669.
31. 2 nanoparticles. Journal of Nanoscience and Nanotechnology 2011, 11:3065-3074.
32. Thomas W., Hesterberg, Long C.M., Lapin C.A., Hamade A.K., Valberg P.A. Diesel exhaust particulate (DEP) and nanoparticle exposures: what do DEP human clinical studies tell about potential human health hazards of nanoparticles?. Inhalation Toxicology 2010, 22:679-694.
33. Warheit D.B., Frame S.R. Characterization and reclassification of titanium dioxide-related pulmonary lesions. Journal of Occupational and Environmental Medicine 2006, 48:1308-1313.
34. 2 particles: differential responses related to surface properties. Toxicology 2007, 230:90-104.
35. Zhang D.H., Cohn L., Ray P., Bottomly K., Ray A. Transcription factor GATA-3 is differentially expressed murine Th1 and Th2 cells and controls Th2-specific expression of the interleukin-5 gene. Journal of Biological Chemistry 1997, 272:21597-21603.
36. 2 particles exert size and surface coating dependent retention and lesions on the murine brain. Toxicology Letters 2011, 207:73-81.
37. Zhao J., Xie Y., Qian C., Li L., Jiang R., Kan H., Chen R., Song W. Imbalance of Th1 and Th2 cells in cardiac injury induced by ambient fine particles. Toxicology Letters 2012, 208:225-231.
38. Zheng W.P., Flavell R.A. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 1997, 89:587-596.
39. Zhu K., Ye J., Wu M., Cheng H. Expression of Th1 and Th2 cytokine-associated transcription factors, T-bet and GATA-3, in peripheral blood mononuclear cells and skin lesions of patients with psoriasis vulgaris. Archives of Dermatological Research 2010, 302:517-523.
40. Zolnik B.S., Gonzalez-Fernandez A., Sadrieh N., Dobrovolskaia M.A. Minireview: nanoparticles and the immune system. Endocrinology 2010, 151:458-465.